Detection of cardiovascular disease
Price: 590 €
Turnaround time: 4 - 6 weeks
Cardiovascular risk
Nowadays, functions of cardiovascular risk, which examine clinical and analytical aspects of the patient (smoking, age, systolic blood pressure, cholesterol and diabetes) are used to prevent this disease, classifying the population in different risk categories. However, in Spain, 85% of cardiovascular events occur in people classified as low or moderate risk, which shows that clinical and biochemical factors are insufficient to predict the real risk.
Therefore, to improve the prediction of individual cardiovascular risk we must consider the patient’s genetic constitution, as this multifactor disease depends both on environmental and genetic factors.
New genetic screening techniques allow comprehensive markers’ searches that help detecting susceptibility to a disease, diagnosing at an early stage and anticipating the treatment through preventive medicine. As a result, it helps to increase the patient’s life quality and the therapeutic success.
Studies on large populations of cardiovascular patients have revealed a number of genetic polymorphisms associated with cardiovascular risk, notably a series in which that association is independent of the classical risk factors.
The CardioChip
CardioChip is a service of predictive and personalized medicine that jointly analyzes genetic, clinical-biochemical information and the patient's habits, in order to determine an accurate and specific cardiovascular risk in the long term. The CardioChip offers relevant information for the doctor, who may establish individually preventive guidelines or the most appropriate measures before the disease manifests.
The CardioChip is not a diagnostic, but a personalized predictive research tool with direct impact on:
-
Personalized re-evaluation of the classic risk, depending on twelve genetic variants directly associated with myocardial infarction, angina pectoris, revascularization and coronary heart disease.
-
Evaluation of the genetic load associated with classic risk factors, analyzing more than 120 variants related to hypertension, dyslipidemia, obesity, diabetes mellitus, thrombosis and dependence to nicotine, which act as modulators of the cardiovascular risk.
- Genetic personalized advice, offered by experts, that integrates genetic and clínical-biochemical information, taking into account the patient’s habits.
The CardioChip allows quick and direct access to the relevant genetic information to investigate the individual cardiovascular risk. This test is specially recommended for people classified as low or moderate risk according to the classical parameters, insufficient for a proper evaluation of this group.
The CardioChip predicts patient’s cardiovascular risk basing on their genetic charge and not only on the classical risk factors.
